agilon health, inc.
AGL
$0.42
-$0.02-4.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -188.88M | -110.21M | -104.37M | 12.11M | -105.79M |
| Total Depreciation and Amortization | -6.73M | 7.43M | 7.32M | 6.88M | -4.01M |
| Total Amortization of Deferred Charges | 13.70M | -- | -- | -- | 10.50M |
| Total Other Non-Cash Items | 78.71M | -8.10M | 9.09M | -12.18M | 9.95M |
| Change in Net Operating Assets | 82.67M | 92.72M | 52.88M | -38.79M | 105.77M |
| Cash from Operations | -20.54M | -18.15M | -35.09M | -31.99M | 16.42M |
| Capital Expenditure | -2.97M | -3.18M | -3.25M | -3.85M | -3.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.55M | 21.83M | 73.71M | -19.24M | 26.94M |
| Cash from Investing | 22.58M | 18.66M | 70.46M | -23.09M | 23.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -22.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.00K | -236.00K | -2.58M | -161.00K | -- |
| Cash from Financing | -17.00K | -236.00K | -2.58M | -161.00K | -22.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.03M | 268.00K | 32.79M | -55.24M | 40.07M |